VirtualScopics (Rochester, New York) said the Nasdaq Hearings Panel has granted the company's request to remain listed on the Nasdaq capital market and has allowed the company until Feb. 3, 2009, to regain compliance with the minimum bid price requirement.

The decision of the panel to grant the company's request for continued listing is subject to the condition that the company must have evidenced a closing bid price of $1 or more for a minimum of 10 consecutive trading days by Feb. 3.

In the event the company does not comply with these conditions, its common stock may be suspended from the Nasdaq Capital Market.

VirtualScopics makes imaging solutions to accelerate drug and medical device development.

NewCardio opens Princeton office

NewCardio (Santa Clara, California), a cardiac diagnostic and services company, has opened a new office in Princeton, New Jersey. The new office is positioned to service the many healthcare and life science companies with headquarters in or near New Jersey.

President Vincent Renz said, "NewCardio's new sales and client services office in New Jersey is the most significant indication to date of our accelerating commercialization effort. We believe it is important to place our sales and client service functions in close proximity to the hub of the life science industry. Our ability to directly interface with healthcare and life science leaders and the companies that support them will be augmented by the opening of this office."

Cisbio Bioassays opens new U.S. facility

Cisbio Bioassays (Bagnols-sur-Cèze, France), a member of IBA group and a maker of HTRF (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, said that its U.S. subsidiary, Cisbio US, has moved to a new, expanded facility in Bedford, Massachusetts. The space features a larger laboratory designed to accommodate the growing demand for Cisbio US's custom assay development and labeling services.

Now occupying a 10,000-cubic-foot space, Cisbio US has doubled its laboratory capacity, built a cell-culture facility, and added two assay development scientists, each of whom bring over 10 years of industry experience to its technical team and bring the headcount to double that of two years ago.

Curlin Medical, Zevex adopt the Moog brand

Moog (East Aurora, New York) said that Curlin Medical and Zevex are adopting the Moog brand name. The organizations and product lines will be united to provide comprehensive access to an expanded product portfolio within a single, well-established company.

"While the existing brand names will continue to be associated with the products, this event joins three companies into one cohesive business going forward," said Martin Berardi, president of Moog's Medical Devices Group. "The introduction of the Moog brand into the medical devices market is an important step in the growth of this business."

Moog makes control components and systems. Moog's high-performance systems control military and commercial aircraft, satellites and space vehicles, launch vehicles, missiles, automated industrial machinery, marine and medical equipment.

Harvard gets large donation from alumnus

A business school alumnus has given Harvard University (Cambridge, Massachusetts) its largest individual donation ever — $125 million — to start a bioengineering institute.

The mission of the Hansjorg Wyss Institute for Biologically Inspired Engineering is to discover the engineering principles nature uses to build living things, then use that information to create devices and technologies to meet medical needs.

Wyss, an engineer and entrepreneur, earned his MBA from Harvard in 1965.

The institute will bring together experts from numerous disciplines, including robotics, biology and surgery. It will be located in a science complex being built in Boston's Allston neighborhood.

OtisMed gets ISO certification

Orthopedic technology company OtisMed (Alameda, California) has been awarded ISO 13485:2003 certification for its quality management system by one of the world's largest notified bodies, BSI Management Systems. The international standard for the medical device industry, ISO 13485:2003 verifies OtisMed's ability to provide medical devices and related services that consistently meet customer needs and quality requirements around the world.